Title | JUBLIA® (efinaconazole): For the treatment of toenail fungus |
Description | Discover JUBLIA® (efinaconazole), an FDA-approved prescription topical solution for toenail fungus (onychomycosis). |
Keywords | JUBLIA, toenail fungus, topical, treatment of toenail fungus, antifungal medication, FDA-approved |
kerydin.com |
inkfreemd.com |
orthorxaccess.com |
toenailfungi.org |
nationalnailfungus.org |
lolmania.eu |
viidii.info |
2020desi.com |
loto.hn |
mumkeyjones.tv |
forodvd.com |
mnz.co.nz |
anon-ib.co |
emucoach.com |
Jubliarx.com was created 11 years ago. According to Alexa, it has a global traffic rank of #2,364,077 globally. Jubliarx.com receives approximately 8,048 unique visitors per month. Web server is located in United States and has an IP address 45.60.76.248.
Creation date | 2013-09-11 |
Expiration date | 2022-09-11 |
Registrar | MarkMonitor, Inc. |
Name servers |
|
IP address | 45.60.76.248 |
Server located | United States |
Host name | 45.60.76.248 |
Global Rank | 2,364,077 |
Delta (90 Days) | -2,977,758 |
Most Popular In Country | n/a |
Country Rank | n/a |
Host | Type | TTL | Data |
---|---|---|---|
jubliarx.com | A | 3599 |
ip: 45.60.73.248 |
jubliarx.com | A | 3599 |
ip: 45.60.76.248 |
jubliarx.com | NS | 86400 |
target: ns6.markmonitor.com |
jubliarx.com | NS | 86400 |
target: ns5.markmonitor.com |
jubliarx.com | NS | 86400 |
target: ns3.markmonitor.com |
jubliarx.com | NS | 86400 |
target: ns1.markmonitor.com |
jubliarx.com | NS | 86400 |
target: ns7.markmonitor.com |
jubliarx.com | NS | 86400 |
target: ns4.markmonitor.com |
jubliarx.com | NS | 86400 |
target: ns2.markmonitor.com |
jubliarx.com | SOA | 86400 |
mname: ns1.markmonitor.com rname: hostmaster.markmonitor.com serial: 2019043003 refresh: 86400 retry: 3600 expire: 2592000 minimum-ttl: 172800 |
jubliarx.com | TXT | 3600 |
txt: _globalsign-domain-verification=kQxeXON0egy4P9JMIYPsCCMHOiLxgagLNTuXToOchp |
Cache-Control: public, no-cache="Set-Cookie" Content-Type: text/html; charset=utf-8 Vary: Accept-Encoding Set-Cookie: dnn_IsMobile=False; path=/; HttpOnly Set-Cookie: language=en-US; path=/; HttpOnly Set-Cookie: .ASPXANONYMOUS=4uuqick-vs4BpB6zZWVPfxOC2kG2x-zR89IWOjtEePU1-AKzV-NdqA8a84hwtvY8regXor2ZXA31tQ0AUBl_KeDmR_rW16ZOK84wYmHmgwSV067g0; expires=Mon, 25-Jan-2021 00:29:57 GMT; path=/; HttpOnly Set-Cookie: Analytics_VisitorId=2bf5b0eb-0a4d-4696-bdaa-1b7792893ed0; expires=Wed, 16-Dec-2020 13:49:57 GMT; path=/; HttpOnly Set-Cookie: Analytics=SessionId=3bbfa5e5-84b7-4520-b016-8a031d69002f&TabId=12344&ContentItemId=-1; expires=Mon, 16-Nov-2020 14:49:57 GMT; path=/; HttpOnly Set-Cookie: dnn_IsMobile=False; path=/; HttpOnly Set-Cookie: language=en-US; path=/; HttpOnly Set-Cookie: .ASPXANONYMOUS=4uuqick-vs4BpB6zZWVPfxOC2kG2x-zR89IWOjtEePU1-AKzV-NdqA8a84hwtvY8regXor2ZXA31tQ0AUBl_KeDmR_rW16ZOK84wYmHmgwSV067g0; expires=Mon, 25-Jan-2021 00:29:57 GMT; path=/; HttpOnly Set-Cookie: Analytics_VisitorId=2bf5b0eb-0a4d-4696-bdaa-1b7792893ed0; expires=Wed, 16-Dec-2020 13:49:57 GMT; path=/; HttpOnly Set-Cookie: Analytics=SessionId=3bbfa5e5-84b7-4520-b016-8a031d69002f&TabId=12344&ContentItemId=-1; expires=Mon, 16-Nov-2020 14:49:57 GMT; path=/; HttpOnly Set-Cookie: __RequestVerificationToken=3bjyiRutjrbBVNaFdCAR_9P4-g4iXrffXH3OC4QbGW12b4yQ-R9NZRZGi6i4xsSBdFmgHw2; path=/; HttpOnly Set-Cookie: visid_incap_288881=64oXDeu9Qg6fxt6pNpqUH4SDsl8AAAAAQUIPAAAAAACz9JUgXq9lQYaKkrZqCug7; expires=Tue, 16 Nov 2021 08:30:13 GMT; HttpOnly; path=/; Domain=.jubliarx.com Set-Cookie: nlbi_288881=cdEqBo1/gAk0hBNWfyf2gQAAAACT3Jtt1H7uEXWyKwgd/12n; path=/; Domain=.jubliarx.com Set-Cookie: incap_ses_530_288881=a0gDKJqvKBIymspucvBaB4SDsl8AAAAAgmOtIuLSyaWzazsE2NqGIA==; path=/; Domain=.jubliarx.com Set-Cookie: ___utmvmsaumctY=URJHqlMDvGM; path=/; Max-Age=900 Set-Cookie: ___utmvasaumctY=msbSeOx; path=/; Max-Age=900 Set-Cookie: ___utmvbsaumctY=NZP X-UA-Compatible: IE=edge X-XSS-Protection: 1; mode=block X-Frame-Options: SAMEORIGIN Date: Mon, 16 Nov 2020 13:49:57 GMT XksOKalg: mtR; path=/; Max-Age=900 X-CDN: Incapsula Transfer-Encoding: chunked X-Iinfo: 3-277663122-277663131 NNNN CT(19 53 0) RT(1605534596575 37) q(0 0 0 4) r(1 1) U12 x-encoded-content-encoding: gzip |
Domain Name: jubliarx.com Registry Domain ID: 1827252297_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2020-08-11T02:35:07-0700 Creation Date: 2013-09-11T20:12:30-0700 Registrar Registration Expiration Date: 2022-09-11T00:00:00-0700 Registrar: MarkMonitor, Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895770 Domain Status: clientUpdateProhibited (https://www.icann.org/epp#clientUpdateProhibited) Domain Status: clientTransferProhibited (https://www.icann.org/epp#clientTransferProhibited) Domain Status: clientDeleteProhibited (https://www.icann.org/epp#clientDeleteProhibited) Registrant Organization: Valeant Pharmaceuticals International Registrant State/Province: NJ Registrant Country: US Registrant Email: Select Request Email Form at https://domains.markmonitor.com/whois/jubliarx.com Admin Organization: Valeant Pharmaceuticals International Admin State/Province: NJ Admin Country: US Admin Email: Select Request Email Form at https://domains.markmonitor.com/whois/jubliarx.com Tech Organization: Valeant Pharmaceuticals International Tech State/Province: NJ Tech Country: US Tech Email: Select Request Email Form at https://domains.markmonitor.com/whois/jubliarx.com Name Server: ns7.markmonitor.com Name Server: ns5.markmonitor.com Name Server: ns6.markmonitor.com Name Server: ns4.markmonitor.com Name Server: ns2.markmonitor.com Name Server: ns3.markmonitor.com Name Server: ns1.markmonitor.com DNSSEC: unsigned URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/ |